| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/11/2010 | WO2010015792A1 Nitrogen containing heterocyclic compounds useful as bifunctional modulators of m3 receptors and beta-2 receptors |
| 02/11/2010 | WO2010015036A1 Biological applications of steroid binding domains |
| 02/11/2010 | WO2010015032A1 Methods of treating and preventing glucose toxicity |
| 02/11/2010 | US20100035994 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 02/11/2010 | US20100035992 Methods and Compositions for Treating Inflammation and Inflammation-Related Pathologies |
| 02/11/2010 | US20100035954 Acid addition salts of muscarinic receptor antagonists |
| 02/11/2010 | US20100035943 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 02/11/2010 | US20100035936 Heterocyclyl substituted tetrahydronaphthalene derivatives as 5-ht7 receptor ligands |
| 02/11/2010 | US20100035906 Dipyridyl-dihydropyrazolones and their use |
| 02/11/2010 | US20100035891 Pharmaceutically Active Compounds |
| 02/11/2010 | US20100035853 Method for preventing or treating cisplatin-induced nephrotoxicity |
| 02/11/2010 | US20100035842 Amino alcohol compounds or phosphonic acid derivatives thereof |
| 02/11/2010 | CA2733506A1 Biological applications of steroid binding domains |
| 02/11/2010 | CA2732762A1 Urotensin ii receptor antagonists |
| 02/11/2010 | CA2731897A1 Diazepine and diazocane compounds as mc4 agonists |
| 02/10/2010 | EP1701951B1 Modulators of peripheral 5-ht receptors |
| 02/10/2010 | CN100588649C Method for producing condensed imidazole compound, reformatsky reagent having stable form and production thereof |
| 02/10/2010 | CN100588647C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/09/2010 | US7659407 Pharmaceutical compounds |
| 02/09/2010 | US7659272 N-[phenyl or heteroaryl carbonoyl pyridyl] arylsulfonamides; antiinflammatory, antianaphylactic agents; transplant rejection, gastointestinal, respriatory system and skin disorders |
| 02/09/2010 | US7659269 Substituted indolealkanoic acids |
| 02/09/2010 | US7659267 2-(3-cyanophenyl)-4H-1,3-benzothiazin-4-one; cardiovascular, bone or joint diseases, infectious, inflammatory, kidney diseases; safe and good effects of cell death inhibition, Migration Inhibitory Factor (MIF) binding |
| 02/09/2010 | CA2440760C Substituted pyrazolopyrimidines and thiazolopyrimidines used as analgesics |
| 02/09/2010 | CA2439593C Heterocyclic compounds for aging-related and diabetic vascular complications |
| 02/09/2010 | CA2438704C Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
| 02/09/2010 | CA2413061C Serine protease inhibitors |
| 02/04/2010 | WO2010014836A2 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | WO2010013785A1 Adsorbent, cleansing agent, remedy for kidney disease and functional food |
| 02/04/2010 | WO2010013595A1 (5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative |
| 02/04/2010 | WO2010013494A1 Pharmaceutical composition comprising botulinum neurotoxin preparation incapable of being synaptically transported, and use thereof |
| 02/04/2010 | WO2010012817A2 5ht7 receptor ligands and compositions comprising the same |
| 02/04/2010 | WO2010012611A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/04/2010 | WO2010012399A1 Indolylamides as modulators of the ep<sb>2</sb> receptor |
| 02/04/2010 | US20100029922 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 02/04/2010 | US20100029919 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 02/04/2010 | US20100029733 Bicyclic nitrogen-containing heterocyclic compounds |
| 02/04/2010 | US20100029719 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/04/2010 | US20100029690 Nitrogen-containing heterocyclic compounds |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029628 2,4,5-Substituted Piperidines as Renin Inhibitors |
| 02/04/2010 | US20100029599 Indolylamides as modulators of the EP2 receptor |
| 02/04/2010 | US20100028469 Extracts of Cranberry and Methods of Using Thereof |
| 02/04/2010 | US20100028468 Formulations containing thymoquinone for urinary health |
| 02/04/2010 | US20100028455 Nutritional supplement |
| 02/04/2010 | US20100028449 Fermented milk product and use thereof |
| 02/04/2010 | US20100028374 C-type lectin transmembrane antigen expressed in human prostate cancer and uses therof |
| 02/04/2010 | US20100028364 Inhibition of sox9 function in the treatment of proteoglycan-associated pathophysiological conditions |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028331 Antagonists of activin-actriia and uses for increasing red blood cell levels |
| 02/04/2010 | CA2732323A1 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | CA2731358A1 5/5-or 5/6-membered condensed ring cycloalkylamine derivative |
| 02/04/2010 | CA2728096A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
| 02/03/2010 | EP2149560A1 1-substituted tetrahydroisoquinoline compound |
| 02/03/2010 | EP2149374A1 Pharmaceutical composition comprising the combinaton of the anti-microbial agent ciprofloxacin and the antioxidant agent ascorbic acid for the treatment of urinary infections |
| 02/03/2010 | EP2149373A1 5HT7 receptor ligands and compositions comprising the same |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN100586425C Cinnamon poria capsule and its preparation process |
| 02/02/2010 | US7655760 Antibodies to the polypeptide hormone phosphatonin |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655631 Pharmaceutical preparations and methods for inhibiting tumors |
| 02/02/2010 | US7655408 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 02/02/2010 | CA2530159C N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2315205C Substituted 2-aryl-4-amino-quinazolines, methods for the prodution ans use thereof as medicaments |
| 01/28/2010 | WO2010010909A1 Therapeutic agent for chronic renal failure |
| 01/28/2010 | WO2010010464A2 Fesoterodine substantially free of dehydroxy impurity |
| 01/28/2010 | US20100022649 Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis From the Royal Palm (Roystonea regia) Fruits |
| 01/28/2010 | US20100022519 Heterocyclic-substituted piperidine compounds and the uses thereof |
| 01/28/2010 | US20100022484 4-Chromenonyl-1,4-dihydropyridines and their use |
| 01/28/2010 | US20100021574 Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis from the Royal Palm (Roystonea regia) Fruits |
| 01/28/2010 | US20100021528 Conformable structured therapeutic dressing |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | US20100021382 Pyrazine Derivatives and Uses Thereof |
| 01/28/2010 | CA2730599A1 Therapeutic agent for chronic renal failure |
| 01/27/2010 | EP2146726A1 Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions |
| 01/27/2010 | EP2146693A2 Solifenacin compositions |
| 01/27/2010 | CN101633645A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN101633644A N3 alkylated benzimidazole derivatives as mek inhibitors |
| 01/27/2010 | CN100584854C Efficient parts of hydrangea paniculata, their preparing method and compositions and use thereof |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584826C Preparation of r-5-(2-(2-ethoxyphenoxyethylamino)propyl)-2-methoxybenzenesulphonamide hydrochloride of high chemical purity |
| 01/27/2010 | CN100584819C Substituted 4-aminocyclohexanol derivatives |
| 01/27/2010 | CN100584323C Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders |
| 01/26/2010 | US7652155 Diamine derivative, production process therefor and antioxidant |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652138 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7651698 Prolonged release bioadhesive therapeutic systems |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/26/2010 | CA2393083C Use of hypoglycemic agent for treating impaired glucose metabolism |
| 01/26/2010 | CA2299470C Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007944A1 Nitrogenated bicyclic heterocyclic compound |
| 01/21/2010 | WO2010007943A1 Nitrogenated heterocyclic compound |
| 01/21/2010 | WO2010007552A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010006817A1 Supplementation of propane-1,2,3-triol and water in fasting subjects |